SHP Wealth Management’s GoodRx Holdings GDRX Stock Holding History

SHP Wealth Management’s Portfolio GDRX Stock Details GDRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72	Hold	25	–	–	﹤0.01%	1949
2026 Q1	$49	Hold	25	–	–	﹤0.01%	1792
2025 Q4	$68	Buy	+25	New	+$82	﹤0.01%	1513

Other funds holding GDRX

FPM

Francisco Partners Management San Francisco, California $361M AUM 30.56% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SLG

Silver Lake Group Menlo Park, California $4.58B AUM 24.86% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

PTC

Petrus Trust Company Dallas, Texas $1.06B AUM 4.66% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

SHP Wealth Management's GDRX Position: Q2 2026 in Review

SHP Wealth Management held its GoodRx Holdings (GDRX) position steady in Q2 2026 at 25 shares worth $72. The position accounts for ﹤0.01% of the portfolio, ranked #1949.

SHP Wealth Management first reported a position in GDRX in Q4 2025 and has held it in 3 quarters since. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

SHP Wealth Management held 25 shares of GoodRx Holdings worth $72 as of Q2 2026.
SHP Wealth Management left its GoodRx Holdings share count unchanged in Q2 2026.
GoodRx Holdings made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1949 holding.
SHP Wealth Management first reported a position in GoodRx Holdings in Q4 2025 and has held it in 3 quarters since.
162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.